Notice Pursuant to the National Cooperative Research and Production Act of 1993-Marine Well Containment Venture, 62570 [2010-25206]
Download as PDF
<![CDATA[
62570
Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and CMX intends
to file additional written notifications
disclosing all changes in membership.
On March 12, 2010, CMX filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on April 16, 2010 (75 FR 20003).
The last notification was filed with
the Department on May 28, 2010. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on July 14, 2010 (75 FR 40851).
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. 2010–25212 Filed 10–8–10; 8:45 am]
BILLING CODE 4410–11–M
DEPARTMENT OF JUSTICE
Antitrust Division
srobinson on DSKHWCL6B1PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Marine Well Containment
Venture
Notice is hereby given that, on August
18, 2010, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Marine Well
Containment Venture (‘‘MWCV’’) has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing (1) the identities
and nationalities of the parties to the
production venture and any person who
controls a party to the venture and (2)
the nature and objectives of the venture.
The notifications were filed for the
purpose of invoking the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances.
Pursuant to Section 6(b) of the Act,
the identities of the parties to the
venture are: Chevron USA, Inc.,
Houston, TX; ConocoPhillips Co.,
Houston, TX; ExxonMobil Development
Co., Houston, TX; and Shell Offshore
Inc., Houston, TX. The general area of
MWCV’s planned activity is (i) to
design, produce (assemble and/or
construct), operate, maintain, and own a
system to provide emergency
hydrocarbon well containment and
related non-emergency services in the
Gulf of Mexico and potentially in other
regions; and (ii) to perform and sponsor
VerDate Mar<15>2010
17:43 Oct 08, 2010
Jkt 223001
related research and development
activities.
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. 2010–25206 Filed 10–8–10; 8:45 am]
BILLING CODE 4410–11–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated March 10, 2008, and
published in the Federal Register on
March 19, 2008 (73 FR 14841), Chemica,
Inc., 316 West 130th Street, Los
Angeles, California 90061, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
methamphetamine (1105), a basic class
of controlled substance listed in
schedule II.
The above-listed controlled substance
is an intermediate in the manufacture of
Benzphetamine, a schedule III nonnarcotic controlled substance. The
methamphetamine will not be sold as a
commercial product in the domestic
market.
A comment and objection was
received. However, after a thorough
review of this matter, DEA has
concluded that issues raised in the
comment and objection do not warrant
the denial of this application.
DEA has considered the factors in 21
U.S.C. 823(a) and determined that the
registration of Chemica, Inc. to
manufacture the listed basic class of
controlled substance is consistent with
the public interest at this time. DEA has
investigated Chemica, Inc. to ensure that
the company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: October 5, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated June 17, 2010, and
published in the Federal Register on
June 28, 2010 (75 FR 36683), Siegfried
(USA), 33 Industrial Park Road,
Pennsville, New Jersey 08070, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Gamma Hydroxybutyric Acid (2010), a
basic class of controlled substance listed
in schedule I.
The company plans to manufacture
the listed controlled substance in bulk
for sale to customers.
Three comments were received. Two
of the three comments supported the
granting of registration as a bulk
manufacturer of the basic class of
controlled substance listed to this
applicant.
The third comment objected to the
granting of registration. However, after a
thorough review of this matter, DEA has
concluded that the issues raised in the
comment and objection do not warrant
the denial of this application.
DEA has considered the factors in 21
U.S.C. 823(a) and determined that the
registration of Siegfried (USA) to
manufacture the listed basic class of
controlled substance is consistent with
the public interest at this time. DEA has
investigated Siegfried (USA) to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: October 5, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–25539 Filed 10–8–10; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2010–25540 Filed 10–8–10; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00073
Fmt 4703
Sfmt 9990
E:\FR\FM\12OCN1.SGM
12OCN1
]]>Agencies
[Federal Register Volume 75, Number 196 (Tuesday, October 12, 2010)]
[Notices]
[Page 62570]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-25206]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Marine Well Containment Venture
Notice is hereby given that, on August 18, 2010, pursuant to
Section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Marine Well Containment
Venture (``MWCV'') has filed written notifications simultaneously with
the Attorney General and the Federal Trade Commission disclosing (1)
the identities and nationalities of the parties to the production
venture and any person who controls a party to the venture and (2) the
nature and objectives of the venture. The notifications were filed for
the purpose of invoking the Act's provisions limiting the recovery of
antitrust plaintiffs to actual damages under specified circumstances.
Pursuant to Section 6(b) of the Act, the identities of the parties
to the venture are: Chevron USA, Inc., Houston, TX; ConocoPhillips Co.,
Houston, TX; ExxonMobil Development Co., Houston, TX; and Shell
Offshore Inc., Houston, TX. The general area of MWCV's planned activity
is (i) to design, produce (assemble and/or construct), operate,
maintain, and own a system to provide emergency hydrocarbon well
containment and related non-emergency services in the Gulf of Mexico
and potentially in other regions; and (ii) to perform and sponsor
related research and development activities.
Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 2010-25206 Filed 10-8-10; 8:45 am]
BILLING CODE 4410-11-M
